Get the Stockscreener App
5.15
9.34%
0.44
After Hours:
5.14
-0.01
-0.19%
Exagen Inc Stock (XGN) Forecast
The Exagen Inc (XGN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.6642, representing a -67.68% decrease from the current price of $5.15. The highest analyst price target is $3.2005, and the lowest is $0.128.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XGN Price Target
Average 6.8075
(+32.18% Upside)
Is Exagen Inc (XGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.53 | Neutral |
| STOCH(9,6) | 63.51 | Neutral |
| STOCHRSI(14) | 20.10 | Neutral |
| MACD(12,26) | 0.5366 | Sell |
| ADX(14) | 47.56 | Buy |
| William %R | -53.77 | Neutral |
| CCI(14) | -6.7532 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.245
Sell
|
5.1531
Sell
|
| MA20 |
4.735
Buy
|
4.7557
Buy
|
| MA50 |
3.5942
Buy
|
3.9705
Buy
|
| MA100 |
3.2585
Buy
|
3.3847
Buy
|
| MA200 |
2.4996
Buy
|
2.871
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, XGN could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on XGN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.53 indicates that XGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 63.51 indicates that XGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.1 indicates that XGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 47.56 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -6.7532 indicates that XGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term XGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Exagen Inc financial reports and earnings history, Exagen Inc (XGN) stock could reach $7.4543 by 2030, $2.9982 by 2040 and $12.66 by 2050. See the projected annual prices until 2050 of the Exagen Inc stock below:
- Exagen Inc (XGN) is expected to reach an average price of $27.19 in 2035, with a high prediction of $28.61 and a low estimate of $27.19. This indicates an $427.95% rise from the last recorded price of $5.15.
- Exagen Inc (XGN) stock is projected to chart a bullish course in 2040, with an average price target of $2.6833, representing an $-47.90% surge from its current level. The forecast ranges from a conservative $2.7244 to a sky-high $2.9982.
- Our analysts predict Exagen Inc (XGN) to jump 18.17% by 2045, soaring from $6.2355 to an average price of $6.0856, potentially reaching $6.6858. While $6.2355 is the low estimate, the potential upside is significant.
- Exagen Inc (XGN) stock is expected to climb by 2050, reaching an average of $12.05, a $133.94% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.66 and $12.09, respectively, highlighting the market's uncertainty.
Exagen Inc Stock (XGN) Year by Year Forecast
Exagen Inc Stock (XGN) Price Forecast for 2025
Exagen Inc Stock (XGN) is expected to reach an average price of $6.8075 in 2025, with a high prediction of $13.49 and a low estimate of $0.1214. This indicates an +32.18% rise from the last recorded price of $5.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.0855 | $0.128 | $3.2005 | -59.50% |
| February, 2025 | $1.0544 | $0.592 | $2.408 | -79.53% |
| March, 2025 | $0.8144 | $1.1494 | $0.9556 | -84.19% |
| April, 2025 | $0.5118 | $1.1718 | $1.1335 | -90.06% |
| May, 2025 | $2.0483 | $0.6668 | $4.5757 | -60.23% |
| June, 2025 | $0.2083 | $0.3717 | $1.8908 | -95.95% |
| July, 2025 | $3.6509 | $0.8209 | $4.7209 | -29.11% |
| August, 2025 | $2.9809 | $1.6965 | $4.7234 | -42.12% |
| September, 2025 | $2.991 | $2.401 | $3.796 | -41.92% |
| October, 2025 | $4.0936 | $0.1214 | $4.7036 | -20.51% |
| November, 2025 | $7.0636 | $2.8311 | $7.0636 | +37.16% |
| December, 2025 | $8.8962 | $6.2487 | $13.49 | +72.74% |
Exagen Inc Stock (XGN) Price Forecast for 2026
The predicted value for Exagen Inc (XGN) in 2026 is set at an average of $5.726. Estimates vary from a peak of $11.39 to a trough of $0.0632, indicating an +11.18% surge from the present price of $5.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.5862 | $5.4812 | $11.39 | +27.89% |
| February, 2026 | $6.1563 | $4.0539 | $7.6388 | +19.54% |
| March, 2026 | $3.7564 | $1.4013 | $7.3302 | -27.06% |
| April, 2026 | $4.7589 | $2.7529 | $7.2439 | -7.59% |
| May, 2026 | $2.989 | $2.6765 | $5.2014 | -41.96% |
| June, 2026 | $4.149 | $0.209 | $4.639 | -19.44% |
| July, 2026 | $4.8916 | $3.0503 | $4.9816 | -5.02% |
| August, 2026 | $3.2367 | $2.9417 | $5.4041 | -37.15% |
| September, 2026 | $3.7942 | $2.3692 | $5.7742 | -26.33% |
| October, 2026 | $0.4943 | $0.3143 | $4.9884 | -90.40% |
| November, 2026 | $2.9743 | $0.0632 | $3.0243 | -42.25% |
| December, 2026 | $1.4369 | $0.1994 | $3.0769 | -72.10% |
Exagen Inc Stock (XGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Exagen Inc (XGN) is $1.7527, with a high forecast of $3.5049 and a low forecast of $0.000461. This indicates an -65.97% decrease from the last price of $5.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.443 | $0.0619 | $2.2994 | -91.40% |
| February, 2027 | $0.887 | $0.6005 | $1.037 | -82.78% |
| March, 2027 | $1.4004 | $0.000461 | $1.5195 | -72.81% |
| April, 2027 | $2.6704 | $1.8029 | $1.0329 | -48.15% |
| May, 2027 | $2.0203 | $2.4228 | $2.2203 | -60.77% |
| June, 2027 | $0.9777 | $1.4277 | $1.1402 | -81.02% |
| July, 2027 | $0.5723 | $0.2227 | $2.1423 | -88.89% |
| August, 2027 | $2.0676 | $1.3552 | $1.8376 | -59.85% |
| September, 2027 | $2.9119 | $2.0052 | $1.9025 | -43.46% |
| October, 2027 | $3.725 | $3.54 | $3.345 | -27.67% |
| November, 2027 | $3.6549 | $3.6185 | $3.5049 | -29.03% |
| December, 2027 | $2.9324 | $3.1124 | $2.8999 | -43.06% |
Exagen Inc Stock (XGN) Price Forecast for 2028
In 2028, Exagen Inc (XGN) is projected to reach an average price of $1.9686, with a high projection of $3.0629 and a low estimate of $0.8743. This indicates an -61.77% fall from the last price of $5.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.9723 | $3.0623 | $3.0629 | -42.29% |
| February, 2028 | $2.4023 | $2.5423 | $2.4498 | -53.35% |
| March, 2028 | $2.4297 | $2.4095 | $2.4362 | -52.82% |
| April, 2028 | $2.5396 | $2.4949 | $2.3921 | -50.69% |
| May, 2028 | $1.9671 | $2.0671 | $2.1421 | -61.80% |
| June, 2028 | $1.197 | $1.359 | $1.6645 | -76.76% |
| July, 2028 | $0.8369 | $1.1094 | $1.0845 | -83.75% |
| August, 2028 | $1.3144 | $1.0144 | $1.0024 | -74.48% |
| September, 2028 | $1.0543 | $1.2042 | $1.1294 | -79.53% |
| October, 2028 | $0.8543 | $0.8743 | $0.8718 | -83.41% |
| November, 2028 | $1.0317 | $1.0267 | $0.7892 | -79.97% |
| December, 2028 | $1.2216 | $1.2392 | $1.2342 | -76.28% |
Exagen Inc Stock (XGN) Price Forecast for 2029
The 2029 price forecast for Exagen Inc Stock (XGN) is $8.3834 on average, with a high prediction of $16.75 and a low estimate of $0.0119. This represents an +62.78% increase from the previous price of $5.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8291 | $1.1588 | $1.1391 | -83.90% |
| February, 2029 | $0.759 | $0.7766 | $0.8108 | -85.26% |
| March, 2029 | $0.269 | $0.3249 | $0.354 | -94.78% |
| April, 2029 | $0.0311 | $0.0913 | $0.2449 | -99.40% |
| May, 2029 | $0.1237 | $0.0458 | $0.441 | -97.60% |
| June, 2029 | $0.0663 | $0.1137 | $0.3787 | -98.71% |
| July, 2029 | $0.0292 | $0.0119 | $0.0638 | -99.43% |
| August, 2029 | $16.41 | $0.0151 | $15.58 | +218.74% |
| September, 2029 | $15.48 | $16.59 | $16.75 | +200.68% |
| October, 2029 | $12.18 | $12.08 | $13.39 | +136.50% |
| November, 2029 | $3.8596 | $8.6186 | $10.93 | -25.06% |
| December, 2029 | $5.6794 | $4.9545 | $3.7694 | +10.28% |
Exagen Inc Stock (XGN) Price Forecast for 2030
Exagen Inc Stock (XGN) is expected to reach an average price of $11.22 in 2030, with a high forecast of $14.20 and a low forecast of $8.2444. This signifies an +117.91% surge from the last price of $5.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.83 | $8.2444 | $7.4543 | +110.37% |
| February, 2030 | $12.33 | $11.58 | $9.3293 | +139.50% |
| March, 2030 | $12.81 | $14.89 | $12.73 | +148.82% |
| April, 2030 | $11.77 | $11.89 | $11.66 | +128.62% |
| May, 2030 | $14.49 | $13.39 | $14.20 | +181.34% |
| June, 2030 | $14.04 | $14.48 | $14.04 | +172.60% |
| July, 2030 | $13.47 | $14.34 | $14.20 | +161.62% |
| August, 2030 | $10.70 | $11.19 | $11.36 | +107.83% |
| September, 2030 | $12.33 | $11.39 | $11.64 | +139.48% |
| October, 2030 | $8.6282 | $11.46 | $13.35 | +67.54% |
| November, 2030 | $9.0881 | $9.0881 | $8.8482 | +76.47% |
| December, 2030 | $8.868 | $9.168 | $8.708 | +72.19% |
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):